We were especially interested in evaluating established adipokines such as adiponectin and leptin, as well as novel proinflammatory adipokines, i.e., omentin, chemerin, and MCP-1 were shown to induce insulin resistance, endothelial dysfunction, and systemic inflammation [50]. The gene discussed is ITLN1; the disease is endothelial dysfunction.